BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38861331)

  • 1. An attenuated lymphocytic choriomeningitis virus vector enhances tumor control in mice partly via IFN-I.
    Chung YR; Awakoaiye B; Dangi T; Irani N; Fourati S; Penaloza-MacMaster P
    J Clin Invest; 2024 Jun; ():. PubMed ID: 38861331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication-attenuated r3LCMV vectors potentiate tumor control via IFN-I.
    Chung YR; Awakoaiye B; Dangi T; Fourati S; Penaloza-MacMaster P
    bioRxiv; 2023 Dec; ():. PubMed ID: 38106001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest.
    Emonet SF; Garidou L; McGavern DB; de la Torre JC
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3473-8. PubMed ID: 19208813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
    Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancer.
    Schmidt S; Bonilla WV; Reiter A; Stemeseder F; Kleissner T; Oeler D; Berka U; El-Gazzar A; Kiefmann B; Schulha SC; Raguz J; Habbeddine M; Scheinost M; Qing X; Lauterbach H; Matushansky I; Pinschewer DD; Orlinger KK
    Oncoimmunology; 2020 Sep; 9(1):1809960. PubMed ID: 33457095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.
    Schleiss MR; Berka U; Watson E; Aistleithner M; Kiefmann B; Mangeat B; Swanson EC; Gillis PA; Hernandez-Alvarado N; Fernández-Alarcón C; Zabeli JC; Pinschewer DD; Lilja AE; Schwendinger M; Guirakhoo F; Monath TP; Orlinger KK
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection.
    Zhou S; Kurt-Jones EA; Mandell L; Cerny A; Chan M; Golenbock DT; Finberg RW
    Eur J Immunol; 2005 Mar; 35(3):822-30. PubMed ID: 15724245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
    Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications.
    Tober R; Banki Z; Egerer L; Muik A; Behmüller S; Kreppel F; Greczmiel U; Oxenius A; von Laer D; Kimpel J
    J Virol; 2014 May; 88(9):4897-907. PubMed ID: 24554655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
    Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
    J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.
    Fu W; Chu L; Han X; Liu X; Ren D
    J Gene Med; 2008 Jun; 10(6):690-701. PubMed ID: 18338832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.
    Li W; Hofer MJ; Jung SR; Lim SL; Campbell IL
    J Virol; 2014 Jul; 88(13):7578-88. PubMed ID: 24760883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.
    Zhou S; Cerny AM; Fitzgerald KA; Kurt-Jones EA; Finberg RW
    J Virol; 2012 Oct; 86(20):11254-65. PubMed ID: 22875973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alphavirus vectors for cancer therapy.
    Quetglas JI; Ruiz-Guillen M; Aranda A; Casales E; Bezunartea J; Smerdou C
    Virus Res; 2010 Nov; 153(2):179-96. PubMed ID: 20692305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack.
    Bonilla WV; Kirchhammer N; Marx AF; Kallert SM; Krzyzaniak MA; Lu M; Darbre S; Schmidt S; Raguz J; Berka U; Vincenti I; Pauzuolis M; Kerber R; Hoepner S; Günther S; Magnus C; Merkler D; Orlinger KK; Zippelius A; Pinschewer DD
    Cell Rep Med; 2021 Mar; 2(3):100209. PubMed ID: 33763654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma.
    Rodriguez-Madoz JR; Liu KH; Quetglas JI; Ruiz-Guillen M; Otano I; Crettaz J; Butler SD; Bellezza CA; Dykes NL; Tennant BC; Prieto J; González-Aseguinolaza G; Smerdou C; Menne S
    J Virol; 2009 Dec; 83(23):12266-78. PubMed ID: 19740992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type I interferon receptor deficient mice from viral challenge.
    Krolik M; Csepregi L; Hartmann F; Engetschwiler C; Flatz L
    Vaccine; 2021 Feb; 39(8):1257-1264. PubMed ID: 33518468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment.
    Raguz J; Pinto C; Pölzlbauer T; Habbeddine M; Rosskopf S; Strauß J; Just V; Schmidt S; Bidet Huang K; Stemeseder F; Schippers T; Stewart E; Jez J; Berraondo P; Orlinger KK; Lauterbach H
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation.
    Shaabani N; Khairnar V; Duhan V; Zhou F; Tur RF; Häussinger D; Recher M; Tumanov AV; Hardt C; Pinschewer D; Christen U; Lang PA; Honke N; Lang KS
    J Autoimmun; 2016 Feb; 67():82-89. PubMed ID: 26553386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
    Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.